19/02/2022
We are now taking bookings for administering the Novavax Covid-19 vaccinations starting week commencing 20th Feb 2022.
The Novavax product - known by the brand name Nuvaxovid - was shown to be 89% effective against catching symptomatic Covid-19 in clinical trials.
The jab, a protein adjuvant vaccine, is based on technology used for decades to protect people from diseases such as hepatitis and shingles.
It delivers copies of the spike protein on the surface of the virus directly into a person's cells, stimulating the immune system to produce antibodies and T-cells.
An extra ingredient, an adjuvant, then helps boost the immune response.
The original research was conducted against both the earlier Wuhan and Alpha variants of the virus.
In December, Novavax said two doses were also effective in generating an immune response against the now dominant Omicron variant, first identified in South Africa.
Please call our friendly team on 07 3277 6686 or SMS 04 3277 2067 if you or anyone you know are interested in getting their first or second dose of this long awaited spike protein based vaccine.
